Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Chronic Subdural Hematoma With or Without Embolization of Middle Meningeal Artery in Canada (EMMA-Can)- A Randomized Control Trial.

NCT04750200 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT04750200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Chronic Subdural Hematoma With or Without Embolization of Middle Meningeal Artery in Canada (EMMA-Can)- A Randomized Control Trial.
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2021
Completion date
August 31, 2026
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma